2021
DOI: 10.1016/j.matt.2021.09.014
|View full text |Cite
|
Sign up to set email alerts
|

Machine learning for next-generation nanotechnology in healthcare

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 10 publications
(15 citation statements)
references
References 10 publications
0
14
0
1
Order By: Relevance
“…A key challenge for current ML toolkits is to develop robust predictive models with limited (low) data while effectively addressing observational and model uncertainties. 32 Working with real-world data, i.e., either scarce, sparse, 33 unbalanced 34 and/or incomplete 35 remains the ultimate challenge and the most common scenario in ML for chemistry. We envision that low data scenarios offer opportunities for targeted and untargeted serendipity (Fig.…”
Section: Low Data 'Failed' Experiments and Information As Curiosity C...mentioning
confidence: 99%
“…A key challenge for current ML toolkits is to develop robust predictive models with limited (low) data while effectively addressing observational and model uncertainties. 32 Working with real-world data, i.e., either scarce, sparse, 33 unbalanced 34 and/or incomplete 35 remains the ultimate challenge and the most common scenario in ML for chemistry. We envision that low data scenarios offer opportunities for targeted and untargeted serendipity (Fig.…”
Section: Low Data 'Failed' Experiments and Information As Curiosity C...mentioning
confidence: 99%
“…Additionally, before reaching their target these nucleic acids must resist nuclease degradation in vivo and avoid the reticuloendothelial system and renal clearance 196 repositories is challenging owing to the broad procedures, terms, abbreviations and acronyms of the scientific field 111 . c | Machine learning will allow generation of predictable models for in silico nanoparticle design taking into account physico-chemical properties (size, zeta potential) and their in vitro and in vivo response 47,205 . d | Nanoparticle design is envisioned to focus on precision medicine therapies, instead of one-size-fits-all strategies 44 .…”
Section: Limitations and Optimizationsmentioning
confidence: 99%
“…Not only is their characterization difficult but there is also non-uniformity and often insufficient physico-chemical data in the research reports. The lack of standardization in nanomedicine research reports jeopardizes the comparison of different nanomaterials and the assessment of engineering design approaches, which in turn jeopardizes the comparison with other studies, the fundamental understanding of the bio-nano interface and successful translation to the clinic 205 . Concerning the biodistribution, it is assumed that non-viral nanocarriers accumulate preferentially in certain tissues, based on the perfusion.…”
Section: Limitations and Optimizationsmentioning
confidence: 99%
“…Por outro lado, técnicas de aprendizado de máquina e inteligência artificial são usadas para avaliar conjuntos de dados de nanomateriais para encontrar padrões e correlações entre propriedades físico-químicas e suas aplicações, muitas vezes indetectáveis por outros tipos de análises [34][35][36]. Nesse sentido, abordagens computacionais utilizando ciência intensiva de dados para modelagem e predição de estrutura/propriedade possui enorme potencial para desenvolver o uso e a aplicação da nanotecnologia na área da saúde [37].…”
Section: Ciência Intensiva De Dadosunclassified